|
|
|
|
|
|
Vistagen Therap. Com (VTGN)
|
|
1.82 +0.05 (+2.82%)
|
8/18/2017 4:00pm
|
|
Open:
|
1.80
|
Pre. Close:
|
1.77
|
|
High:
|
1.94
|
Low:
|
1.70
|
|
Volume:
|
26,540
|
Market Cap:
|
17.07M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
1.91 - 1.93
|
1.93 - 2.02
|
|
Low:
|
1.61 - 1.63
|
1.63 - 1.7
|
|
Close:
|
1.75 - 1.77
|
1.77 - 1.88
|
|
|
|
|
|
|
Technical analysis (as of: 2017-08-18 4:49:44 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 2.20 One year: 2.39
|
|
Support:
|
Support1: 1.61 Support2: 1.34
|
|
Resistance:
|
Resistance1:
1.88 Resistance2: 2.05
|
|
Pivot:
|
1.82 
|
|
Moving Averages:
|
MA(5): 1.77  MA(20): 1.86
MA(100): 1.91 MA(250): 2.82
|
|
MACD:
|
MACD(12,26):
-0.03 Signal(12,26,9): -0.02
|
|
%K %D:
|
%K(14,3): 45.45 %D(3): 39.14
|
|
RSI:
|
RSI(14): 49.58
|
|
52-Week:
|
High: 4.69
Low: 1.60 Change(%): -48.0
|
|
Average Vol(K):
|
3-Month: 4567
10-Days 2222
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.VTGN has closed below upper band by 50.0%. Bollinger Bands are 35.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Wed, 11 May 2016 20:06:25 GMT
Buy Vistagen, Another Promising Company In The Novel Antidepressant Space.
Tue, 04 Oct 2016 10:52:30 GMT
VistaGen Therapeutics Appoints Mark A. McPartland Vice President of Corporate ...
Mon, 14 Nov 2016 21:26:11 GMT
VistaGen Therapeutics Reports Second Quarter 2017 Financial Results and ...
Thu, 01 Jun 2017 20:48:45 GMT
VistaGen: Creating A New, Different Kind Of Antidepressant
Thu, 22 Sep 2016 12:00:00 GMT
VistaGen Therapeutics Provides Business Outlook and Sets Corporate Milestones
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
